Daniela Acerbi - Concepedia

Author

Daniela Acerbi

Chiesi (France)

Also Known As

D Acerbi, D. Acerbi, Daniela Acerbi

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Chiesi (France)Chiesi (Italy)Chiesi Foundation UCB Pharma (Belgium)Medicines Evaluation Unit

About

Daniela Acerbi is an author at Chiesi (France) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	24	495
2	Allergy	2	2	32
3	Biochemistry	2	2	48
4	Biomolecular Engineering	1	1	13
5	Geriatrics	1	1	10

Daniela Acerbi

Publications

818

Citations

H-Index

Page 1

	Year	Citations
Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients Wilfried De Backer, A. Devolder, Gianluigi Poli, Journal of Aerosol Medicine and Pulmonary Drug Delivery	2010	171
Antiinflammatory activity and bioavailability of percutaneous piroxicam. P Schiantarelli, S Cadel, Daniela Acerbi, PubMed InflammationMedicinal ChemistryAnti-inflammatoryPercutaneous PiroxicamOphthalmology	1982	51
Simultaneous determination of levodopa methyl ester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromatography with electrochemical detection Ivano Rondelli, Daniela Acerbi, Fabrizia Mariotti, Journal of Chromatography B Biomedical Sciences and Applications Electrochemical DetectionMedicineBioanalysisAnalytical ChemistryLiquid Chromatography	1994	46
Modulite® technology: pharmacodynamic and pharmacokinetic implications Ashley Woodcock, Daniela Acerbi, Gianluigi Poli Respiratory Medicine PharmacologyModulite® TechnologyPharmaceutical TechnologyDrug Delivery System	2002	44
Lung Deposition of Formoterol HFA (Atimos <sup>®</sup> /Forair <sup>®</sup> ) in Healthy Volunteers, Asthmatic and COPD Patients Sabine Häußermann, Daniela Acerbi, Peter Brand, Journal of Aerosol Medicine	2007	37
Clinical Pharmacology Study of Bramitob??, a Tobramycin Solution for Nebulization, in Comparison with Tobi?? Gianluigi Poli, Daniela Acerbi, Roberto Pennini, Pediatric Drugs Clinical Pharmacology StudyTobramycin SolutionPharmacologyPathologyPharmacotherapy	2007	31
Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo‐controlled, crossover study Catherine M. Houghton, Stephen J. Langley, Satnam Singh, British Journal of Clinical Pharmacology	2004	31
Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man. Barry G. Woodcock, Daniela Acerbi, P G Merz, PubMed Molecular PharmacologyPharmaceutical ScienceHealthy SubjectsPharmacological StudyPharmacology	1993	27
Systemic Exposure and Implications for Lung Deposition with an Extra-Fine Hydrofluoroalkane Beclometasone Dipropionate/Formoterol Fixed Combination Jean Bousquet, Gianluigi Poli, Daniela Acerbi, Clinical Pharmacokinetics Acute Lung InjuryLung DepositionRespiratory ToxicologyMedicineSystemic Exposure	2009	26
Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man. P Schiantarelli, Daniela Acerbi, G. Bovis PubMed Plasma Half-lifePharmacokinetic ModelingBiochemistryLow ExcretionMedicine	1981	26

Page 1